---
title: Newsroom | biopharma
description: biopharma |
---

[![Life Science Newswire 2](https://news.lifesciencenewswire.com/hs-fs/hubfs/Life%20Science%20Newswire%202.png?width=203&height=60&name=Life%20Science%20Newswire%202.png "Life Science Newswire 2")](https://lifesciencenewswire.com/)

- [Newsroom](https://news.lifesciencenewswire.com/newsroom)
- [Back to the main site](https://lifesciencenewswire.com/)

![LSNewswire-main-header-banner-v2-1](https://news.lifesciencenewswire.com/hubfs/LSNewswire-main-header-banner-v2-1.jpg "LSNewswire-main-header-banner-v2-1")

# Newsroom

#### Categories ![Arrow](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/sidebar.svg "Arrow")

#### Subscribe![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/subscribe-rss-button.svg)

![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/close-button.svg)

### Choose a Category

- [Agriculture (1)](https://news.lifesciencenewswire.com/newsroom/tag/agriculture)
- [AI (1)](https://news.lifesciencenewswire.com/newsroom/tag/ai)
- [Analytical Chemistry (42)](https://news.lifesciencenewswire.com/newsroom/tag/analytical-chemistry)
- [Biomanufacturing (35)](https://news.lifesciencenewswire.com/newsroom/tag/biomanufacturing)
- [biopharma (21)](https://news.lifesciencenewswire.com/newsroom/tag/biopharma)
- [Bioprocessing (16)](https://news.lifesciencenewswire.com/newsroom/tag/bioprocessing)
- [Biotechnology (251)](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology)
- [Cell Culture (10)](https://news.lifesciencenewswire.com/newsroom/tag/cell-culture)
- [Clinical Diagnostics (36)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-diagnostics)
- [clinical research (6)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research)
- [Clinical Research & Trials (114)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials)
- [Computing & Technology (62)](https://news.lifesciencenewswire.com/newsroom/tag/computing-it)
- [Corporate, Finance & Investor (287)](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor)
- [COVID-19 (86)](https://news.lifesciencenewswire.com/newsroom/tag/covid-19)
- [Diagnostics & Hospital Laboratory (35)](https://news.lifesciencenewswire.com/newsroom/tag/diagnostics-hospital-laboratory)
- [Digital Pathology (1)](https://news.lifesciencenewswire.com/newsroom/tag/digital-pathology)
- [Drug Discovery & Development (152)](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development)
- [Energy & Environment (15)](https://news.lifesciencenewswire.com/newsroom/tag/energy-environment)
- [excipients (1)](https://news.lifesciencenewswire.com/newsroom/tag/excipients)
- [Food & Beverage (8)](https://news.lifesciencenewswire.com/newsroom/tag/food-beverage)
- [General Chemistry (7)](https://news.lifesciencenewswire.com/newsroom/tag/general-chemistry)
- [General Laboratory (58)](https://news.lifesciencenewswire.com/newsroom/tag/general-laboratory)
- [General Science (5)](https://news.lifesciencenewswire.com/newsroom/tag/general-science)
- [Healthcare (135)](https://news.lifesciencenewswire.com/newsroom/tag/healthcare)
- [Hospital Management (7)](https://news.lifesciencenewswire.com/newsroom/tag/hospital-management)
- [Life Science (26)](https://news.lifesciencenewswire.com/newsroom/tag/life-science)
- [Manufacturing (2)](https://news.lifesciencenewswire.com/newsroom/tag/manufacturing)
- [Materials Science (2)](https://news.lifesciencenewswire.com/newsroom/tag/materials-science)
- [Medical Devices & Technology (26)](https://news.lifesciencenewswire.com/newsroom/tag/medical-devices-technology)
- [Microbiology & Infection Control (18)](https://news.lifesciencenewswire.com/newsroom/tag/microbiology-infection-control)
- [Microscopy & Imaging (47)](https://news.lifesciencenewswire.com/newsroom/tag/microscopy-imaging)
- [Nanotech (2)](https://news.lifesciencenewswire.com/newsroom/tag/nanotech)
- [Omics & Genetics (87)](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics)
- [Pathology (5)](https://news.lifesciencenewswire.com/newsroom/tag/pathology)
- [Pharma (118)](https://news.lifesciencenewswire.com/newsroom/tag/pharma)
- [Pharmacy (5)](https://news.lifesciencenewswire.com/newsroom/tag/pharmacy)
- [Research (47)](https://news.lifesciencenewswire.com/newsroom/tag/research)
- [Veterinary (6)](https://news.lifesciencenewswire.com/newsroom/tag/veterinary)
- [Water (8)](https://news.lifesciencenewswire.com/newsroom/tag/water)

See all

### Subscribe to Email Updates

<https://news.lifesciencenewswire.com/newsroom/cellcarta-launches-digital-pathology-and-ai-consortium-to-accelerate-platform-agnostic-biomarker-innovation-across-drug-development>

 Categories: [biopharma](https://news.lifesciencenewswire.com/newsroom/tag/biopharma), [Digital Pathology](https://news.lifesciencenewswire.com/newsroom/tag/digital-pathology), [AI](https://news.lifesciencenewswire.com/newsroom/tag/ai)

#### [CellCarta Launches Digital Pathology and AI Consortium to Accelerate Platform-Agnostic Biomarker Innovation Across Drug Development](https://news.lifesciencenewswire.com/newsroom/cellcarta-launches-digital-pathology-and-ai-consortium-to-accelerate-platform-agnostic-biomarker-innovation-across-drug-development)

 July 15, 2026

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/cellcarta-launches-digital-pathology-and-ai-consortium-to-accelerate-platform-agnostic-biomarker-innovation-across-drug-development)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/cellcarta-launches-digital-pathology-and-ai-consortium-to-accelerate-platform-agnostic-biomarker-innovation-across-drug-development#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Jul 15, 2026, 1:44:59 PM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/alithea-genomics-launches-early-access-program-for-mercurius-1536-drug-seq-bringing-transcriptomics-to-compound-screening-scale>

 Categories: [Omics & Genetics](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics), [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology), [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development), [biopharma](https://news.lifesciencenewswire.com/newsroom/tag/biopharma)

#### [Alithea Genomics Launches Early Access Program for MERCURIUS™ 1536 DRUG-seq, Bringing Transcriptomics to Compound Screening Scale](https://news.lifesciencenewswire.com/newsroom/alithea-genomics-launches-early-access-program-for-mercurius-1536-drug-seq-bringing-transcriptomics-to-compound-screening-scale)

 June 16, 2026

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/alithea-genomics-launches-early-access-program-for-mercurius-1536-drug-seq-bringing-transcriptomics-to-compound-screening-scale)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/alithea-genomics-launches-early-access-program-for-mercurius-1536-drug-seq-bringing-transcriptomics-to-compound-screening-scale#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Jun 16, 2026, 1:01:59 PM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/leica-biosystems-and-cellcarta-expand-collaborative-companion-diagnostic-development-model-to-accelerate-commercialization-globally>

 Categories: [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor), [Clinical Diagnostics](https://news.lifesciencenewswire.com/newsroom/tag/clinical-diagnostics), [biopharma](https://news.lifesciencenewswire.com/newsroom/tag/biopharma)

#### [Leica Biosystems and CellCarta expand collaborative companion diagnostic development model to accelerate commercialization globally](https://news.lifesciencenewswire.com/newsroom/leica-biosystems-and-cellcarta-expand-collaborative-companion-diagnostic-development-model-to-accelerate-commercialization-globally)

 June 1, 2026

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/leica-biosystems-and-cellcarta-expand-collaborative-companion-diagnostic-development-model-to-accelerate-commercialization-globally)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/leica-biosystems-and-cellcarta-expand-collaborative-companion-diagnostic-development-model-to-accelerate-commercialization-globally#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Jun 1, 2026, 2:18:00 PM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/gennext-and-agilent-unveil-groundbreaking-technology-integration-to-accelerate-high-value-decision-making-in-biopharmaceutical-research>

 Categories: [Research](https://news.lifesciencenewswire.com/newsroom/tag/research), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor), [biopharma](https://news.lifesciencenewswire.com/newsroom/tag/biopharma)

#### [GenNext and Agilent unveil groundbreaking technology integration to accelerate high-value decision making in biopharmaceutical research](https://news.lifesciencenewswire.com/newsroom/gennext-and-agilent-unveil-groundbreaking-technology-integration-to-accelerate-high-value-decision-making-in-biopharmaceutical-research)

 September 11, 2024

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/gennext-and-agilent-unveil-groundbreaking-technology-integration-to-accelerate-high-value-decision-making-in-biopharmaceutical-research)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/gennext-and-agilent-unveil-groundbreaking-technology-integration-to-accelerate-high-value-decision-making-in-biopharmaceutical-research#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Sep 11, 2024, 2:00:00 PM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/synexa-life-sciences-expands-biomarker-discovery-capabilities-with-the-addition-of-olink-target-platform>

 Categories: [General Laboratory](https://news.lifesciencenewswire.com/newsroom/tag/general-laboratory), [biopharma](https://news.lifesciencenewswire.com/newsroom/tag/biopharma)

#### [Synexa Life Sciences expands biomarker discovery capabilities with the addition of Olink® target platform](https://news.lifesciencenewswire.com/newsroom/synexa-life-sciences-expands-biomarker-discovery-capabilities-with-the-addition-of-olink-target-platform)

 March 4, 2024

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/synexa-life-sciences-expands-biomarker-discovery-capabilities-with-the-addition-of-olink-target-platform)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/synexa-life-sciences-expands-biomarker-discovery-capabilities-with-the-addition-of-olink-target-platform#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Mar 4, 2024, 12:00:00 PM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/gennext-technologies-announces-partnership-with-emery-pharma-on-full-solution-biopharmaceutical-protein-footprinting-services>

 Categories: [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology), [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development), [biopharma](https://news.lifesciencenewswire.com/newsroom/tag/biopharma)

#### [GenNext® Technologies announces partnership with Emery Pharma on full-solution biopharmaceutical protein footprinting services](https://news.lifesciencenewswire.com/newsroom/gennext-technologies-announces-partnership-with-emery-pharma-on-full-solution-biopharmaceutical-protein-footprinting-services)

 May 17, 2023

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/gennext-technologies-announces-partnership-with-emery-pharma-on-full-solution-biopharmaceutical-protein-footprinting-services)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/gennext-technologies-announces-partnership-with-emery-pharma-on-full-solution-biopharmaceutical-protein-footprinting-services#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on May 17, 2023, 12:30:00 PM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/new-application-specific-lc-system-to-precisely-deliver-high-purity-products-or-isolation-of-contaminants>

 Categories: [Analytical Chemistry](https://news.lifesciencenewswire.com/newsroom/tag/analytical-chemistry), [biopharma](https://news.lifesciencenewswire.com/newsroom/tag/biopharma)

#### [New application-specific LC system to precisely deliver high-purity products or isolation of contaminants](https://news.lifesciencenewswire.com/newsroom/new-application-specific-lc-system-to-precisely-deliver-high-purity-products-or-isolation-of-contaminants)

 October 10, 2022

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/new-application-specific-lc-system-to-precisely-deliver-high-purity-products-or-isolation-of-contaminants)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/new-application-specific-lc-system-to-precisely-deliver-high-purity-products-or-isolation-of-contaminants#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Oct 10, 2022, 1:00:00 PM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/synexa-life-sciences-acquires-finnish-cro-syrinx-bioanalytics-to-expand-bioanalysis-capabilities-in-clinical-drug-development>

 Categories: [Pharma](https://news.lifesciencenewswire.com/newsroom/tag/pharma), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor), [biopharma](https://news.lifesciencenewswire.com/newsroom/tag/biopharma)

#### [Synexa Life Sciences acquires Finnish CRO Syrinx Bioanalytics to expand bioanalysis capabilities in clinical drug development.](https://news.lifesciencenewswire.com/newsroom/synexa-life-sciences-acquires-finnish-cro-syrinx-bioanalytics-to-expand-bioanalysis-capabilities-in-clinical-drug-development)

 May 19, 2022

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/synexa-life-sciences-acquires-finnish-cro-syrinx-bioanalytics-to-expand-bioanalysis-capabilities-in-clinical-drug-development)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/synexa-life-sciences-acquires-finnish-cro-syrinx-bioanalytics-to-expand-bioanalysis-capabilities-in-clinical-drug-development#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on May 19, 2022, 11:00:00 AM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/arctoris-and-evariste-technologies-form-a-joint-venture-to-identify-novel-small-molecule-cmet-inhibitors-for-non-small-cell-lung-cancer>

 Categories: [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor), [biopharma](https://news.lifesciencenewswire.com/newsroom/tag/biopharma)

#### [Arctoris and Evariste Technologies form a joint venture to identify novel small molecule cMET inhibitors for non-small cell lung cancer](https://news.lifesciencenewswire.com/newsroom/arctoris-and-evariste-technologies-form-a-joint-venture-to-identify-novel-small-molecule-cmet-inhibitors-for-non-small-cell-lung-cancer)

 March 7, 2022

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/arctoris-and-evariste-technologies-form-a-joint-venture-to-identify-novel-small-molecule-cmet-inhibitors-for-non-small-cell-lung-cancer)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/arctoris-and-evariste-technologies-form-a-joint-venture-to-identify-novel-small-molecule-cmet-inhibitors-for-non-small-cell-lung-cancer#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Mar 7, 2022, 11:30:00 AM

- [Tweet](https://twitter.com/share)

[All posts](https://news.lifesciencenewswire.com/newsroom/all) [Next](https://news.lifesciencenewswire.com/newsroom/tag/biopharma/page/2)

##### Browse more news

## Recent releases

<https://news.lifesciencenewswire.com/newsroom/ceryx-medical-appoints-professor-zaheer-yousef-obe-as-chief-medical-officer>

#### [Ceryx Medical appoints Professor Zaheer Yousef OBE as Chief Medical Officer](https://news.lifesciencenewswire.com/newsroom/ceryx-medical-appoints-professor-zaheer-yousef-obe-as-chief-medical-officer)

 September 21, 2026

Leading heart failure cardiologist and RSA-Pace principal investigator joins as the company prepares its next clinical study Ceryx Medical (Ceryx), th...

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/ceryx-medical-appoints-professor-zaheer-yousef-obe-as-chief-medical-officer)

<https://news.lifesciencenewswire.com/newsroom/qinecsa-selected-as-technology-partner-for-africas-new-continent-wide-medicines-safety-platform>

#### [Qinecsa selected as technology partner for Africa’s new continent-wide medicines safety platform](https://news.lifesciencenewswire.com/newsroom/qinecsa-selected-as-technology-partner-for-africas-new-continent-wide-medicines-safety-platform)

 September 10, 2026

The global pharmacovigilance specialist will help drive one of Africa’s most comprehensive medicines safety initiatives. Qinecsa, the global pharmacov...

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/qinecsa-selected-as-technology-partner-for-africas-new-continent-wide-medicines-safety-platform)

<https://news.lifesciencenewswire.com/newsroom/sakura-finetek-europe-launches-sakura-pathology-network>

#### [Sakura Finetek Europe launches Sakura Pathology Network](https://news.lifesciencenewswire.com/newsroom/sakura-finetek-europe-launches-sakura-pathology-network)

 September 10, 2026

A new initiative to connect and empower early-career pathologists across Europe Sakura Finetek Europe today announced the launch of the Sakura Patholo...

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/sakura-finetek-europe-launches-sakura-pathology-network)

![LS-Newswire-reverse](https://news.lifesciencenewswire.com/hs-fs/hubfs/raw_assets/public/LifeScienceNewswire_June2020/images/LS-Newswire-reverse.png?width=150&name=LS-Newswire-reverse.png "LS-Newswire-reverse")

Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225 

#### Useful information

- [Cookie and privacy policy](https://lifesciencenewswire.com/cookie-privacy-policy/)
- [Website terms and conditions](https://lifesciencenewswire.com/terms-and-conditions)
- [Promotion terms and conditions](https://lifesciencenewswire.com/promotion_terms/)